2021 Virtual PEG Symposium

Lisa joined Merck in January 2010 as an analytical project lead, responsible for ADCs. She brings with her more than 25 years of experience in both organic synthesis and analytical sciences and has had the opportunity to contribute to many projects ranging from discovery to full development, but none has been as exciting as the emergence of ADCs. She also has an extensive chromatography background with experience in integrated LC/MS screening systems.

A molecular biologist by training, Lars has been working in several regulatory positions in pharmaceutical industry (for both drug products and pharmaceutical raw materials) as well as contributing to a number of industry associations, joining Merck in 2012.

Currently, he is responsible for a team of regulatory experts in life science regulatory management. The team is working on regulatory topics mainly related to APIs and excipients, supporting a number of manufacturing sites as well as global activities.

Tobias is a director of process and analytical development at our center of excellence for drug delivery compounds in Schaffhausen, Switzerland. With 20+ years of experience in the pharmaceutical industry, Tobias leverages his broad expertise in process development, technology transfers, scale-up, GMP manufacturing, analytical development and project management to support our CDMO service offerings. He holds a doctoral degree in Chemistry from the University of Konstanz, Germany.